Assignee
AVENTIS PASTEUR
CA·73 granted patents·8 pending applications·896 citations·filing 1994–2008
Top patents by PatentIndex Score
81 records- 0198US6471996B1Biodegradable targetable microparticle delivery systemAVENTIS PASTEUR·Filed 2000·Granted Oct 29, 2002·139 cites·14 claims
- 0294US6780407B1Pox virus comprising DNA sequences encoding CEA and B7 antigenAVENTIS PASTEUR·Filed 2000·Granted Aug 24, 2004·47 cites·12 claims
- 0388US6544752B1Anigenically-marked non-infectious retrovirus-like particlesAVENTIS PASTEUR·Filed 2000·Granted Apr 8, 2003·19 cites·10 claims
- 0487US6309647B1Poxvirus—canine dispemper virus (CDV) or measles virus recombinants and compositions and methods employing the recombinantsAVENTIS PASTEUR·Filed 1999·Granted Oct 30, 2001·66 cites·23 claims
- 0586US6342228B1Diagnostic kits comprising genetically engineered human immunodeficiency virus-like particles containing heterologous antigenic markersAVENTIS PASTEUR·Filed 2000·Granted Jan 29, 2002·16 cites·22 claims
- 0685US6538123B2Vaccine composition for preventing or treating hepatitis CAVENTIS PASTEUR·Filed 2001·Granted Mar 25, 2003·23 cites·21 claims
- 0784US6486135B1Nucleic acid respiratory syncytial virus vaccinesAVENTIS PASTEUR·Filed 2000·Granted Nov 26, 2002·18 cites·7 claims
- 0882US6933137B2Animal component free meningococcal polysaccharide fermentation and seedbank developmentAVENTIS PASTEUR·Filed 2003·Granted Aug 23, 2005·16 cites·19 claims
- 0976US6656472B1Multi oligosaccharide glycoconjugate bacterial meningitis vaccinesAVENTIS PASTEUR·Filed 1999·Granted Dec 2, 2003·35 cites·8 claims
- 1073US7704513B2Nucleic acids and polypeptides specific for pathogenic strains of the Neisseria genusAVENTIS PASTEUR·Filed 2008·Granted Apr 27, 2010·0 cites·6 claims
- 1173US6642025B2Chlamydia antigens and corresponding DNA fragments and uses thereofAVENTIS PASTEUR·Filed 2001·Granted Nov 4, 2003·5 cites·10 claims
- 1273US6623764B1Biodegradable targetable microparticle delivery systemAVENTIS PASTEUR·Filed 1997·Granted Sep 23, 2003·23 cites·16 claims
- 1373US6544527B1Non-infectious, immunogenic, human immunodeficiency virus-like particles devoid of long terminal repeats and a functional pol coding regionAVENTIS PASTEUR·Filed 1996·Granted Apr 8, 2003·22 cites·8 claims
- 1473US6348198B1Lactoferrin receptor proteinAVENTIS PASTEUR·Filed 1999·Granted Feb 19, 2002·25 cites·26 claims
- 1573US6287604B1Biodegradable targetable microparticle delivery systemAVENTIS PASTEUR·Filed 2000·Granted Sep 11, 2001·6 cites·15 claims
- 1672US7384768B2Nucleic acids and polypeptides specific for pathogenic strains of the Neisseria genusAVENTIS PASTEUR·Filed 2004·Granted Jun 10, 2008·2 cites·4 claims
- 1772US6808713B1Chlamydia antigens and corresponding DNA fragments and uses thereofAVENTIS PASTEUR·Filed 1999·Granted Oct 26, 2004·29 cites·19 claims
- 1869US6693087B1Nucleic acid molecules encoding POMP91A protein of ChlamydiaAVENTIS PASTEUR·Filed 1999·Granted Feb 17, 2004·31 cites·16 claims
- 1969US6521745B1Nucleic acid molecules encoding inclusion membrane protein C of ChlamydiaAVENTIS PASTEUR·Filed 1999·Granted Feb 18, 2003·30 cites·6 claims
- 2068US6696065B1Acellular pertussis vaccines and methods of preparation thereofAVENTIS PASTEUR·Filed 1996·Granted Feb 24, 2004·37 cites·10 claims
- 2167US6465171B1CoRT-PCR assay for the discrimination of endogenous reverse transcriptase activity in eukaryotic cell lines from infectious retrovirus contaminationAVENTIS PASTEUR·Filed 2000·Granted Oct 15, 2002·5 cites·12 claims
- 2267US6451322B1Retrovirus like particles made non infectious by a plurality of mutationsAVENTIS PASTEUR·Filed 1999·Granted Sep 17, 2002·11 cites·29 claims
- 2366US7335370B2Chlamydia antigens and corresponding DNA fragments and uses thereofAVENTIS PASTEUR·Filed 2004·Granted Feb 26, 2008·0 cites·21 claims
- 2466US6518030B1Antigentically-marked non-infectious retrovirus-like particlesAVENTIS PASTEUR·Filed 2000·Granted Feb 11, 2003·11 cites·12 claims
- 2565US6399076B2Acellular pertussis vaccines and methods of preparation thereofAVENTIS PASTEUR·Filed 1996·Granted Jun 4, 2002·26 cites·14 claims
- 2663US7008784B1Non-infectious, non-replicating, immunogenic human immunodeficiency virus-like particlesAVENTIS PASTEUR·Filed 1999·Granted Mar 7, 2006·18 cites·5 claims
- 2763US6335018B1High molecular weight major outer membrane protein of moraxellaAVENTIS PASTEUR·Filed 1995·Granted Jan 1, 2002·18 cites·9 claims
- 2862US6440425B1High molecular weight major outer membrane protein of moraxellaAVENTIS PASTEUR·Filed 1996·Granted Aug 27, 2002·11 cites·6 claims
- 2961US6849447B2Protective recombinant Haemophilus influenzae high molecular weight proteinsAVENTIS PASTEUR·Filed 2002·Granted Feb 1, 2005·0 cites·3 claims
- 3061US6548070B1Attenuated strains of mycobacteriaAVENTIS PASTEUR·Filed 2000·Granted Apr 15, 2003·1 cites·5 claims
- 3161US6291208B1Chimeric antibodies for delivery of antigens to selected cells of the immune systemAVENTIS PASTEUR·Filed 1997·Granted Sep 18, 2001·15 cites·8 claims
- 3260US2008112965A1Chlamydia OMP antigenAVENTIS PASTEUR·Filed 2007·Application pending·0 cites
- 3358US2003224004A1Chlamydia antigens and corresponding DNA fragments and uses thereofAVENTIS PASTEUR·Filed 2003·Application pending·0 cites
- 3457US6764682B1Adjuvant compositions containing more than one adjuvantAVENTIS PASTEUR·Filed 1994·Granted Jul 20, 2004·19 cites·15 claims
- 3556US2002037293A1Chlamydia antigens and corresponding DNA fragments and uses thereofAVENTIS PASTEUR·Filed 2001·Application pending·0 cites
- 3655US6503514B1Attenuated strains of mycobacteriaAVENTIS PASTEUR·Filed 2000·Granted Jan 7, 2003·10 cites·4 claims
- 3754US7015033B1Co-expression of recombination proteinsAVENTIS PASTEUR·Filed 2000·Granted Mar 21, 2006·0 cites·4 claims
- 3854US6395469B1Inactivated respiratory syncytial viral vaccinesAVENTIS PASTEUR·Filed 1995·Granted May 28, 2002·9 cites·11 claims
- 3952US2003225017A1Chlamydia antigens and corresponding DNA fragments and uses thereofAVENTIS PASTEUR·Filed 2002·Application pending·0 cites
- 4051US6440424B1High molecular weight major outer membrane protein of moraxellaAVENTIS PASTEUR·Filed 1995·Granted Aug 27, 2002·10 cites·13 claims
- 4151US2003157123A1Chlamydia antigens and corresponding DNA fragments and uses thereofAVENTIS PASTEUR·Filed 2002·Application pending·0 cites
- 4250US6677127B1Nucleic acid respiratory syncytial virus vaccinesAVENTIS PASTEUR·Filed 1999·Granted Jan 13, 2004·5 cites·4 claims
- 4349US6649370B1Chlamydia antigens and corresponding DNA fragments and uses thereofAVENTIS PASTEUR·Filed 1999·Granted Nov 18, 2003·6 cites·10 claims
- 4449US6541250B2Continuous adherent melanocyte cell lineAVENTIS PASTEUR·Filed 2001·Granted Apr 1, 2003·0 cites·8 claims
- 4549US6391313B1Multi-component vaccine to protect against disease caused by Haemophilus influenzae and Moraxella catarrhalisAVENTIS PASTEUR·Filed 1999·Granted May 21, 2002·7 cites·22 claims
- 4649US6309649B1Subunit respiratory syncytial virus vaccine preparationAVENTIS PASTEUR·Filed 1997·Granted Oct 30, 2001·7 cites·22 claims
- 4748US7241449B1Transferrin receptor genes of moraxellaAVENTIS PASTEUR·Filed 1999·Granted Jul 10, 2007·10 cites·4 claims
- 4847US6660275B2Chlamydia antigens and corresponding DNA fragments and uses thereofAVENTIS PASTEUR·Filed 1999·Granted Dec 9, 2003·6 cites·5 claims
- 4947US6342232B1Multi-component vaccine comprising at least three antigens to protect against disease cased by Haemophilus influenzaeAVENTIS PASTEUR·Filed 1999·Granted Jan 29, 2002·6 cites·20 claims
- 5047US2004002455A1Targeted immunogensAVENTIS PASTEUR·Filed 2003·Application pending·0 cites
Showing the top 50 of 81 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →